193 related articles for article (PubMed ID: 22447005)
1. Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry.
Lahtela H; Rubboli A; Schlitt A; Karjalainen PP; Niemelä M; Vikman S; Puurunen M; Weber M; Valencia J; Biancari F; Lip GY; Airaksinen KE;
Circ J; 2012; 76(6):1363-8. PubMed ID: 22447005
[TBL] [Abstract][Full Text] [Related]
2. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
3. Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial.
Dewilde WJ; Janssen PW; Kelder JC; Verheugt FW; De Smet BJ; Adriaenssens T; Vrolix M; Brueren GB; Van Mieghem C; Cornelis K; Vos J; Breet NJ; ten Berg JM
EuroIntervention; 2015 Aug; 11(4):381-90. PubMed ID: 24970794
[TBL] [Abstract][Full Text] [Related]
4. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
[TBL] [Abstract][Full Text] [Related]
6. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.
Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T;
Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700
[TBL] [Abstract][Full Text] [Related]
7. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.
Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GY;
Am Heart J; 2017 Aug; 190():86-93. PubMed ID: 28760217
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.
Suh SY; Kang WC; Oh PC; Choi H; Moon CI; Lee K; Han SH; Ahn T; Choi IS; Shin EK
Heart Vessels; 2014 Sep; 29(5):578-83. PubMed ID: 23974943
[TBL] [Abstract][Full Text] [Related]
9. Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non-valvular atrial fibrillation patients: a multicenter propensity-matched analysis.
Kim TH; Kim JY; Mun HS; Lee HY; Roh YH; Uhm JS; Pak HN; Lee MH; Joung B
J Thromb Haemost; 2015 Feb; 13(2):182-90. PubMed ID: 25472735
[TBL] [Abstract][Full Text] [Related]
10. Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.
Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GYH;
Clin Res Cardiol; 2017 Jun; 106(6):420-427. PubMed ID: 28078448
[TBL] [Abstract][Full Text] [Related]
11. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
Kiviniemi T; Karjalainen P; Pietilä M; Ylitalo A; Niemelä M; Vikman S; Puurunen M; Biancari F; Airaksinen KE
Am J Cardiol; 2012 Jul; 110(1):30-5. PubMed ID: 22464216
[TBL] [Abstract][Full Text] [Related]
12. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
Fischer Q; Georges JL; Le Feuvre C; Sharma A; Hammoudi N; Berman E; Cohen S; Jolivet I; Silvain J; Helft G
Int J Cardiol; 2018 Aug; 264():64-69. PubMed ID: 29776575
[TBL] [Abstract][Full Text] [Related]
13. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
[TBL] [Abstract][Full Text] [Related]
14. Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.
Kiviniemi T; Airaksinen KE; Rubboli A; Biancari F; Valencia J; Lip GY; Karjalainen PP; Weber M; Laine M; Kirchhof P; Schlitt A;
Int J Cardiol; 2015 Mar; 183():105-10. PubMed ID: 25662060
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention.
Kowalewski M; Suwalski P; Raffa GM; Słomka A; Kowalkowska ME; Szwed KA; Borkowska A; Kowalewski J; Malvindi PG; Undas A; Windyga J; Pawliszak W; Anisimowicz L; Carrel T; Paparella D; Lip GYH
Int J Cardiol; 2016 Nov; 223():186-194. PubMed ID: 27541652
[TBL] [Abstract][Full Text] [Related]
16. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.
Kiviniemi T; Karjalainen P; Rubboli A; Schlitt A; Tuomainen P; Niemelä M; Laine M; Biancari F; Lip GY; Airaksinen KE
Am J Cardiol; 2013 Aug; 112(4):493-8. PubMed ID: 23672991
[TBL] [Abstract][Full Text] [Related]
18. Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
Lahtela HM; Bah A; Kiviniemi T; Nammas W; Schlitt A; Rubboli A; Karjalainen PP; Proietti M; Hartikainen JEK; Lip GYH; Airaksinen KEJ
Clin Cardiol; 2017 Dec; 40(12):1264-1270. PubMed ID: 29243834
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy.
Carrié D; Menown I; Oldroyd K; Copt S; Talwar S; Maillard L; Morice MC; Teik LS; Lang I; Urban P
JACC Cardiovasc Interv; 2017 Aug; 10(16):1633-1642. PubMed ID: 28838473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
